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DObjective: The optimal timing of mitral valve surgery for severe mitral regurgitation is controversial. We aimed
to evaluate the changes in left ventricular performance using ventricular energetics and left ventricular mass re-
gression after the surgery to determine the appropriate surgical timing in asymptomatic patients with severe mi-
tral regurgitation.
Methods: Fifty consecutive asymptomatic or minimally symptomatic patients who electively underwent the
surgery for severe mitral regurgitation were studied retrospectively. Contractility (end-systolic elastance), after-
load (effective arterial elastance), and efficiency (ventriculoarterial coupling and ratio of stroke work to pres-
sure–volume area), and left ventricular mass index were measured echocardiographically before and 1 month
after surgery. Two-way repeated-measures analysis of variance was used to compare the parameters between
patients with (n ¼ 17) and without (n ¼ 33) left ventricular dysfunction (ie, ejection fraction 60% and/or
end-systolic dimension 40 mm).
Results: Contractility did not change significantly (P¼ .94) but the afterload increased significantly (P<.0001)
in both groups. Consequently, the efficiency deteriorated significantly (ventriculoarterial coupling, P ¼ .0004;
ratio of stroke work to pressure–volume area, P<.0001). Furthermore, the left ventricular mass index improved
remarkably in both groups (P<.0001). Alternatively, the patients with normal left ventricular function had
greater contractility (P<.0001), less worsened efficiency (P<.0001 and P<.0001, respectively), and a better
left ventricular mass index (P ¼ .0002) after surgery.
Conclusions: Early surgery for severe mitral regurgitation preserves left ventricular performance and improves
left ventricular mass regression in asymptomatic patients with normal ventricular function. (J Thorac Cardiovasc
Surg 2013;146:61-6)Degenerative mitral regurgitation (MR) is the most frequent
cause of organic mitral valve (MV) disease in Western
countries and is often discovered accidentally in asymptom-
atic patients.1
The optimal timing of MV surgery for MR remains con-
troversial, because patients with chronic MR can be asymp-
tomatic for a long period. In particular, the role of early
surgery has been debated.2,3 Rosenhek and colleagues2 re-
ported good outcomes with a watchful strategy in which
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The Journal of Thoracic and Cexaminations. In contrast, the American College of Cardiol-
ogy/American Heart Association guidelines recommend
early surgery for asymptomatic patients with severe MR
and a high probability of MV repair.3
Furthermore, although MV surgery for MR is followed
by left ventricular (LV) adjustment to the new preload and
afterload,4,5 little has been reported on the postoperative
LV mechanics and LV reverse remodeling.
End-systolic elastance (Ees), effective arterial elastance
(Ea), and ventriculoarterial coupling (Ea/Ees), and the
stroke work to pressure–volume area (SW/PVA) ratio en-
able analysis of LV contractility, afterload, and efficiency,
respectively.6,7 These parameters have been validated and
used in previous basic and clinical studies of LV
performance.8-15
An increased LV mass index (LVMI) is reportedly an in-
dependent factor for the development of symptoms in
asymptomatic patients with severe aortic stenosis.16 More-
over, incomplete LVM regression after MV surgery for MR
has been correlated with decreased LV function and the
degree of preoperative tricuspid valve regurgitation.17
The assessment of the postoperative LV performance and
LVM regression in asymptomatic patients should helpardiovascular Surgery c Volume 146, Number 1 61
Abbreviations and Acronyms
Ea ¼ effective arterial elastance
Ees ¼ end-systolic elastance
Ea/Ees ¼ ventriculoarterial coupling
EF ¼ ejection fraction
LV ¼ left ventricular
LVEDVI ¼ LV end-diastolic volume index
LVESVI ¼ LV end-systolic volume index
LVM ¼ LV mass
LVMI ¼ LV mass index
MR ¼ mitral regurgitation
MV ¼ mitral valve
SW/PVA ¼ stroke work/pressure–volume area
(ratio)
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Delucidate the optimal timing of MV surgery for MR. There-
fore, we evaluated the changes in LV performance and LVM
regression after MV surgery on the basis of LV mechanics
and LVMI, respectively, in asymptomatic patients with
chronic severe MR.METHODS
Study Population
A total of 50 consecutive asymptomatic or minimally symptomatic pa-
tients who electively underwent MV surgery for chronic severe MR from
January 1, 2007 to September 30, 2010 at KyushuMedical Center were ret-
rospectively studied. All patients had degenerative or myxomatous valve
disease, and 4 patients had a remote history of endocarditis.
The inclusion criteria were (1) preoperative New York Heart Associa-
tion class I or II; and (2) MR due to degenerative or myxomatous MV
disease, even in the case of a remote history of endocarditis. The patients
who underwent tricuspid annuloplasty, the maze procedure, or closure of
atrial septal defects were not excluded. The exclusion criteria were (1) pre-
operative New York Heart Association class III or IV; (2) associated mitral
stenosis; (3) associated aortic or tricuspid valve replacement or coronary
artery bypass grafting; (4) ischemic MR, cardiomyopathy, rheumatic valve
disease, or acute endocarditis; (5) LVejection fraction (EF) 0.30; and (6)
previous valve surgery.
Surgical Procedures
The MV surgery was performed under cardiopulmonary bypass, with
aortic and bicaval cannulation and moderate hypothermia. Myocardial pro-
tection was achieved using antegrade and retrograde cardioplegia. MV re-
pair (n ¼ 36) was performed singly or in combination with the following
techniques: artificial chordal reconstruction in 17, quadrangular or triangu-
lar resection in 18, commissuroplasty in 11, and an edge-to-edge technique
in 13. Ring annuloplasty was performed in all the MV repair cases. The
posterior leaflet and chords were preserved in the MV replacement cases
(n¼ 14). Finally, 6 and 8 patients received mechanical valves and biologic
prostheses, respectively.
Echocardiographic Data
The MR severity was assessed by transesophageal or transthoracic
echocardiography before and approximately 1 month after the surgery. It
was graded according to the published guidelines using an integrated ap-
proach that included valvular morphologic characteristics, regurgitant jet62 The Journal of Thoracic and Cardiovascular Surgesize in the left atrium, proximal regurgitant jet width, and pulmonary
venous flow pattern.18
LVmechanics. The blood pressure (BP) was measured using the Kor-
otkoff technique and the manchette method. The mean arterial BP was cal-
culated as follows:
Mean arterial BP ¼ ðsystolic BP diastolic BPÞ=3þ diastolic BP
The LV volume was calculated using the Teichholz M-mode method
based on the transthoracic echocardiographic data.19 The LV end-
diastolic volume index (LVEDVI) and LV end-systolic volume index
(LVESVI) were calculated. Next, the EF (%) was calculated as follows:
EF ¼ ð1LVESV=LVEDVÞ 3 100
The Ees, Ea, and Ea/Ees were calculated using an approximation
method on the basis of the arterial BP and volumetric data obtained by
transthoracic echocardiography.8-14 The approximation of Ees and Ea
was as follows:
Ees ¼ mean arterial BP=LVESV
Ea ¼ systolic BP=ðLVEDVLVESVÞ
The LV volume was normalized by the body surface area. Ea/Ees7 and
SW/PVA were calculated as indexes of LV efficiency. The SW/PVA (%)
was calculated as follows20:
SW=PVA ¼ 1=ð1þ 0:5 Ea=EesÞ 3 100
LVM index. The LVM (g) was calculated as follows21:
LVM ¼ 0:80 1:04 ½LVEDDþ posterior wall thickness in diastole
þ septal wall thickness in diatole3LVEDD3þ 0:6
where LVEDD is the LVend-diastolic dimension. The obtained result was
indexed for body surface area in grams per square meter.
Statistical Analysis
For analysis, the patients were grouped as follows: group A, patients
with LV dysfunction (LVEF 60% and/or LV end-systolic dimension
[LVESD] 40 mm); and group B, patients without LV dysfunction
(LVEF>60% and LVESD<40 mm).
The data are presented as the mean  standard deviation. Categorical
variables were compared using the unpaired t test and chi-square test.
Two-way repeated measures analysis of variance was used to compare
the LV parameters before and after surgery. It was used to clarify whether
the repeated (measurement points) and nonrepeated (groups) factors were
significantly different among the levels and whether the interactions be-
tween these factors were significant. The analysis was also used to deter-
mine whether the variables were significantly different between the
measurement points or between the patients groups. The Student-
Newman-Keuls test was used as a post hoc test. A P value less than .05
was considered to be statistically significant.RESULTS
Patient Characteristics
Perioperative and in-hospital deaths did not occur. The
patients in group A had a larger left atrium (P ¼ .006),
LVEDD (P< .0001), and LVESD (P< .0001) and lower
LVEF (P<.0001) than the patients in group B (Table 1).
Moreover, they had a greater rate of atrial fibrillation orry c July 2013
TABLE 1. Baseline characteristics
Parameter
Total
(n ¼ 50)
Group A
(n ¼ 17)
Group B
(n ¼ 33)
P value
(A vs B)
Age (y) 63.9  12.6 62.8  9.5 64.5  14.1 .64
Male 35 (70) 12 (71) 23 (70) .95
BSA (m2) 1.6  0.2 1.7  0.2 1.6  0.2 .14
Smoking 22 (44) 8 (47) 14 (42) .76
Diabetes 8 (16) 3 (18) 5 (15) .82
Hypertension 27 (54) 11 (65) 16 (48) .28
Total cholesterol
(mg/dL)
179  38 185  42 176  37 .44
Serum creatinine
(mg/dL)
0.9  0.2 0.9  0.3 0.9  0.2 .87
ACEI or ARB 33 (66) 14 (82) 19 (58) .08
b-blocker 18 (36) 8 (47) 10 (30) .24
Diuretic 40 (80) 16 (94) 24 (73) .07
Warfarin 24 (48) 11 (65) 13 (39) .09
Antiplatelet agent 11 (22) 5 (29) 6 (18) .37
Af or AF 17 (34) 9 (53) 8 (24) .04
Systolic PAP
(mm Hg)
40.1  14.0 46.8  17.2 36.1  10.2 .01
LA size (mm) 50.5  12.7 57.2  12.0 47.1  11.8 .006
LVEDD (mm) 57.9  7.6 64.6  1.5 54.5  1.0 <.0001
LVESD (mm) 34.7  1.0 43.3  3.0 30.3  3.5 <.0001
LVEF (%) 64.5  10.5 54.7  10.7 69.5  5.9 <.0001
TR .06
Absent 11 (22) 1 (6) 10 (30)
Trivial to mild 29 (58) 10 (59) 19 (58)
Moderate 7 (14) 5 (29) 2 (6)
Severe 3 (6) 1 (6) 2 (6)
Data presented as the mean  standard deviation or number (percentages). Group A,
patients with LV dysfunction; group B, patients without LV dysfunction. BSA, Body
surface area; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin re-
ceptor blocker; Af, atrial fibrillation; AF, atrial flutter; PAP, pulmonary artery pres-
sure; LA, left atrium; LVEDD, left ventricular end-diastolic dimension; LVESD, left
ventricular end-systolic dimension; LVEF, left ventricular ejection fraction; TR, tri-
cuspid regurgitation.
TABLE 2. Surgical data
Parameter
Total
(n ¼ 50)
Group A
(n ¼ 17)
Group B
(n ¼ 33)
P value
(A vs B)
Region of MV prolapse .65
Anterior 14 (28) 4 (24) 10 (30)
Posterior 25 (50) 8 (47) 17 (52)
Bileaflet 11 (22) 5 (29) 6 (18)
MV repair 36 (72) 12 (71) 24 (73) .87
TAP 22 (44) 11 (65) 11 (33) .03
Maze procedure 14 (28) 7 (41) 7 (21) .14
CPB time (min) 179  45 195  49 171  41 .08
Aortic cross-clamp
time (min)
123  39 135  48 116  33 .11
Data presented as mean  SD or number (percentages). Group A, patients with LV
dysfunction; group B, patients without LV dysfunction.MV, Mitral valve; TAP, tricus-
pid annuloplasty; CPB, cardiopulmonary bypass.
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(P ¼ .01). Tricuspid annuloplasty was performed more fre-
quently in group A than in group B (P¼ .03). However, the
cardiopulmonary bypass and aortic cross-clamping times
were not significantly different (Table 2). Echocardiograms
at 1 month after MV repair revealed no MR in 15 patients
and trivial regurgitation in 21 patients. No patient who un-
derwent MV replacement had paravalvular leaks. The mean
gradient across the MV was 2.9 1.1 and 3.6 0.8 mm Hg
at 1 month after MV repair and MV replacement,
respectively.LV Volume and Parameters
As shown in Figure 1, the LVEDVI decreased signifi-
cantly in both groups after surgery (group A, from
170.1  36.0 to 123.7  29.8 mL $ m2; group B, from
126.6 26.3 to 95.1 14.8 mL $m2;P<.0001). However,
group A had a significantly greater LVEDVI than group B
preoperatively and postoperatively (P < .0001). TheThe Journal of Thoracic and Cinteraction of LVEDVI between the groups was not signif-
icant (P ¼ .17).
Although the LVESVI in group A decreased (from 75.1
 14.0 to 65.4  27.3 mL $ m2), it increased slightly in
group B (from 38.4  10.1 to 40.7  9.5 mL $ m2). Group
A had a significantly greater LVESVI than group B preop-
eratively and postoperatively (P<.0001). The interaction of
LVESVI between the groups was not significant (P ¼ .06).
Consequently, the LVEF deteriorated remarkably in both
groups (group A, from 54.7%  10.7% to 47.9% 
14.4%; group B, from 69.5%  5.9% to 57.1%  8.3%;
P<.0001). Moreover, group B had a significantly greater
LVEF than group A pre- and postoperatively (P<.0001).
The interaction of LVEF between the groups was not signif-
icant (P ¼ .16).
LV Performance and LVM Regression Parameters
As shown in Figure 2, the Ees did not change signifi-
cantly (P ¼ .94) in either group A (from 1.2  0.2 to 1.4
 0.6 mm Hg $ m2 $ mL1) or group B (from 2.4  0.8 to
2.1  0.5 mm Hg $ m2 $ mL1). However, the difference
in Ees between the groups was significant (P< .0001).
The interaction of Ees between the groups was not signifi-
cant (P¼ .08). The Ea increased dramatically and similarly
in both groups after surgery (group A, from 1.4 0.6 to 2.1
 0.7 mmHg $m2 $mL1; group B, from 1.4 0.4 to 2.2
0.5 mm Hg $ m2 $ mL1; P<.0001). The interaction of Ea
between the groups was not significant (P ¼ .63).
Consequently, Ea/Ees and SW/PVA deteriorated signifi-
cantly after surgery (group A, from 1.3  0.8 to 1.8  1.2
and 63.6%  11.1% to 56.5%  13.5%; group B, from
0.6  0.2 to 1.1  0.3 and 76.6%  4.8% to 65.7% 
6.8%; P ¼ .0004 and P< .0001, respectively). Group B
had significantly superior Ea/Ees and SW/PVA before
and after surgery compared with group A (P<.0001 and
P< .0001, respectively). The interactions of Ea/Ees and
SW/PVA between the groups were not significant
(P ¼ .83 and P ¼ .29, respectively).ardiovascular Surgery c Volume 146, Number 1 63
FIGURE 1. Changes in left ventricular (LV) volume and ejection fraction (EF) in the patients with (black circles, groupA) and without (white circles, group
B) LV dysfunction. LVEDVI, Left ventricular end-diastolic volume index; LVESVI, left ventricular end-systolic volume index. ***Before versus after
surgery and ###group A versus B denote significant differences (P<.001).
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groups after surgery (group A, from 179.4  38.6 to
136.5  37.5 g $ m2; group B, from 153.0  40.5 to
105.6  24.9 g $ m2; P<.0001; Figure 3). The difference
in the LVMI between the groups was significant
(P ¼ .0002), but the interaction was not (P ¼ .76).
DISCUSSION
The major findings from the present study were as fol-
lows: (1) LV contractility (Ees) remained unchanged, but
the LV afterload (Ea) increased evenly; (2) LV efficiency
(Ea/Ees and SW/PVA) deteriorated; (3) LVM reduced re-
markably; and (4) early surgery preserved LV performance
(greater contractility and less worsened efficiency) and im-
proved LVM regression.
The effects ofMRand subsequentMVsurgery are notwell
understood because of the dramatic hemodynamic changes
after surgery. A better understanding of the LV responses
to changes in preload and afterload would help to clarify
the mechanism of MR and its effect on the left ventricle. In
the present study, we focused on the LV performance and
LVM regression in the early postoperative phase. Suri and
colleagues4 suggested that the early decrease in the LVEFaf-
ter MV surgery is explainable by the compensatory alter-
ations in LV volume and dimension rather than by
postoperative LV dysfunction due to impaired myocardial
contractility. Moreover, Ashikhmina and colleagues564 The Journal of Thoracic and Cardiovascular Surgeindicated that these changes are immediately noticeable after
MV surgery for degenerative MR. Furthermore, they con-
cluded that early LV remodeling after the surgery might be
a compensatory mechanism to ensure a constant forward
stroke volume.4,5 Our postoperative findings were similar
to those of Suri and colleagues4; the patients had decreased
LVEF and LVEDD but unchanged LVESD postoperatively,
and the changes in LV dimension and LVEF in preserved
LV function were superior to those with impaired LV func-
tion. Therefore, we believe that these findings were volumet-
ric adjustments to maintain the forward stroke volume
according to the preoperative LV function.
The LV performance parameters in the present study sup-
port this viewpoint. LV contractility remained unchanged,
but LVafterload significantly increased after the surgery, ir-
respective of the LV functional status. Consequently, LVef-
ficiency worsened. However, the patients with normal LV
function had better LV contractility and efficiency than
those with LV dysfunction. The effect of the deteriorated
LV efficiency remains unknown. However, these findings
show that early surgery should be recommended for patients
with chronic severe MR and normal LV function.
Moreover, Starling22 reported that such patients with pre-
served LVEF have impaired LV contractility that is revers-
ible 1 year after MV surgery. However, Starling22 also
demonstrated that some patients with impaired LV contrac-
tility do not have improved contractile function and LVry c July 2013
FIGURE 2. Changes in left ventricular (LV) performance in patients with (black circles, group A) and without (white circles, group B) LV dysfunction.Ees,
End-systolic elastance; Ea, effective arterial elastance; Ea/Ees, ventriculoarterial coupling; SW/PVA, stroke work/pressure–volume area ratio. ***Before
versus after surgery and ###group A versus B denote significant differences (P<.001).
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and LV efficiency (Ea/Ees or SW/PVA) possibly predict
the recovery of normal LV function.FIGURE 3. Changes in left ventricular mass index in patients with (black
circles, group A) and without (white circles, group B) LV dysfunction.
***Before versus after surgery and ###group Aversus B denote significant
differences (P<.001).
The Journal of Thoracic and CStulak and colleagues17 reported that MV repair for leaf-
let prolapse performed before a decrease in the EF and de-
velopment of significant secondary tricuspid regurgitation
is associated with a greater likelihood of significant LVM
regression after 3 years. In the present study, we found
that the LVM had already regressed in the early postopera-
tive phase. Moreover, the extent of regression was superior
in the patients with normal LV function compared with
those with LV dysfunction. Schuler and colleagues23 and
Zile and colleagues24 observed that patients who achieved
a normal LVEDD after MV replacement had a better func-
tional result than those with persistent LV enlargement. In
our study, the advantage of LVM regression in the patients
with normal LV function was the associated superiority of
the LV performance. At present, LV performance and
LVM regression are not covered in the guidelines of MV
surgery for severe MR. Despite the insufficient follow-up
in our study, we believe that LV performance and LVM re-
gression are important factors for early MV surgery.Study Limitations
First, all data were obtained retrospectively by chart and
database review, which has inherent limitations. Second, the
Simpson method is more suitable than the Teichholzardiovascular Surgery c Volume 146, Number 1 65
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LV diameter values were available in our study. Third, the
approximation of Ees and Ea is not as accurate as measure-
ments obtained using a conductance catheter system, and
the volume intercept could not be measured. This approxi-
mation was validated using a canine right-heart bypass,
which can draw the maximum capacity of a conductance
catheter system.8,15 Furthermore, the validation was
performed only on normal canine hearts, which differ
from diseased human hearts. However, we believe that the
limitations of such an approximation are consistent across
groups and did not detract the validity of our conclusions.
Fourth, the short follow-up period (1 month after surgery)
is another limitation. The LVEF, LV dimension, and LVM
after the MV surgery for chronic severe MR have been
found to improve and lead to recovery of normal LV func-
tion over time.17,25 Studies evaluating the long-term effects
of earlier surgery in terms of LVmechanics are therefore re-
quired. Finally, the New York Heart Association functional
classification system has inherent limitations, which might
have altered the inclusion and exclusion processes. Ideally,
patients should be classified according to the results of an
exercise test. Unfortunately, these data were unavailable
for most of our patients.
CONCLUSIONS
LV efficiency in asymptomatic or minimally symptom-
atic patients with chronic severe MR deteriorates because
of increased LV afterload at 1 month after MV surgery.
However, treated patients with normal LV function benefit
from the greater LV contractility, less worsened LV
efficiency, and better LVM regression. Furthermore, LVM
regression occurs immediately after surgery, and the extent
of LVM regression in the case of normal LV function was
superior to that in the case of LV dysfunction. These data
support the view that early MV surgery for chronic severe
MR optimizes LV performance and LVM regression during
the early postoperative period (1 month after the surgery).
However, long-term evaluations of LV performance and
LVM regression are needed before any definitive conclu-
sion can be drawn.
The present study was prepared in consultation with Professor
Masahiro Nakano, PhD, Junshin Gakuen University, for statistical
analyses.
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